FDA Adverse Event Injury Summary report: N

TELIGEN

MDR report key: 1944530 · Received January 3, 2011

Report

Report Number
2124215-2010-19604
Event Type
Injury
Date Received
January 3, 2011
Date of Event
October 6, 2010
Report Date
October 6, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

BOTH THE CRT-D AND LEAD REMAIN IMPLANTED AND IN SERVICE. NO ADDITIONAL INFORMATION IS AVAILABLE. IF ANY ADDITIONAL INFORMATION DOES BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT A REVISION WAS PERFORMED AFTER NOTING THAT THE PACING IMPEDANCE MEASUREMENTS WERE ABOVE 2000 OHMS. DURING THE PROCEDURE, IT WAS DISCOVERED THAT THE RIGHT VENTRICULAR DEFIBRILLATION LEAD WAS NOT PROPERLY CONNECTED TO THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D). ONCE THE LEAD WAS RECONNECTED TO THE DEVICE, ALL MEASUREMENTS WERE WITHIN NORMAL RANGE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F102

Patients

Seq Age Sex Outcome Treatment
1 74 YR Required Intervention N118| MISMATCH| 4513| H175| 0158